Regeneron Pharmaceuticals, Inc. SEC filings REGN

Regeneron Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Sep 13, 2017. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
10-K Annual report Feb 4, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
10-K Annual report Feb 5, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
10-K Annual report Feb 5, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 21, 2023 Dec 31, 2022
10-K Annual report Feb 6, 2023 Dec 31, 2022
10-K Annual report Feb 7, 2022 Dec 31, 2021
10-K Annual report Feb 8, 2021 Dec 31, 2020
10-K Annual report Feb 7, 2020 Dec 31, 2019
10-K Annual report Feb 7, 2019 Dec 31, 2018
10-K Annual report Feb 8, 2018 Dec 31, 2017

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
REGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NY
Headquarters
Tarrytown, NY
SEC filer status
Large accelerated filer
SEC CIK
872589
Former names
REGENERON PHARMACEUTICALS INC (until Jun 19, 2019)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.